Clinical Dilemmas in Diabetes

Clinical Dilemmas in Diabetes provides evidence-based clinical guidance on the most common and problematic areas of concern encountered by health professionals when diagnosing, treating, and managing patients with diabetes. Topics reflect current interest, specific recent developments, and areas of controversy. Each brief chapter opens with a learning points box to aid easy assimilation of the main issues. Contributors are international and well known diabetes specialists, thus providing a global perspective, writing under the editorial guidance of two Mayo Clinic experts, Professor Adrian Vella and a former president of the American Diabetes Association, Professor Robert Rizza.

Adrian Vella Associate Professor of Medicine, Mayo Clinic College of Medicine, Rochester, USA

Robert Rizza Professor of Medicine and Division Chair for Endocrinology, Mayo Clinic College of Medicine, Rochester, USA

Contributors	p. vii
Preface	p. ix
Prediabetes and the Diagnosis of Diabetes
Is prediabetes a risk factor or is it a disease?	p. 3
Early diagnosis of type 1 diabetes: Useful or a phyrrhic victory?	p. 11
How should secondary causes of diabetes be excluded?	p. 22
Screening patients with prediabetes and diabetes for cardiovascular disease	p. 34
Initial Evaluation and Management of Diabetes
What is the role of self-monitoring in diabetes? Is there a role for postprandial glucose monitoring? How does continuous glucose monitoring integrate into clinical practice?	p. 43
The optimal diet for diabetes is?	p. 56
How to determine when to pursue lifestyle change alone versus pharmacotherapy at diagnosis?	p. 64
Insulin sensitizers versus secretagogues as first-line therapy for diabetes: Rationale for clinical choice	p. 71
Are insulin sensitizers useful additions to insulin therapy?	p. 79
Is there a role for incretin-based therapy in combination with insulin?	p. 91
HbA1c: Is it the most important therapeutic target in outpatient management of diabetes?	p. 96
Management of Associated Risk Factors and Disease
Primary therapy for obesity as the treatment of type 2 diabetes	p. 107
Are statins the optimal therapy for cardiovascular risk in patients with diabetes? Are triglycerides an important independent risk factor for diabetes?	p. 116
The role of bariatric surgery in obese patients with diabetes: Primary or rescue therapy?	p. 127
Hyperglycemia should be avoided in critical illness and the postoperative period	p. 134
Is there an optimal revascularization strategy in diabetic patients with ischemic heart disease?	p. 145
Index	p. 153
Table of Contents provided by Ingram. All Rights Reserved.

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

FREE SHIPPING

Amazon no longer offers textbook rentals. We do!

Clinical Dilemmas in Diabetes

Summary

Author Biography

Table of Contents

Supplemental Materials